We are live on ! Find out more
PC

Paulson & Co Portfolio holdings

AUM $2.58B
1-Year Est. Return 68.51%
This Fund
S&P 500
This Quarter Est. Return
+18.3%
1 Year Est. Return
+68.51%
3 Year Est. Return
+251.48%
5 Year Est. Return
+229.81%
10 Year Est. Return
+881.28%
AUM
$4.63B
AUM Growth
-$360M
Cap. Flow
-$920M
Cap. Flow %
-19.87%
Top 10 Hldgs %
78.2%
Holding
51
New
6
Increased
3
Reduced
5
Closed
14

Top Buys

Rank Stock Value
1
PARA
Paramount Global Class B
PARA
+$232M
2
PVG
PRETIUM RESOURCES INC.
PVG
+$27.5M
3
S
Sprint Corporation
S
+$20.1M
4
TECD
Tech Data Corp
TECD
+$17.2M
5
TIF
Tiffany & Co.
TIF
+$15.8M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$317M
2
AABA
Altaba Inc
AABA
+$148M
3
WCG
Wellcare Health Plans, Inc.
WCG
+$141M
4
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
+$139M
5
BID
Sotheby's
BID
+$106M

Sector Composition

Rank Sector Weight
1 Healthcare 44.89%
2 Communication Services 19.82%
3 Materials 15.14%
4 Miscellaneous 13.33%
5 Financials 4.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BHC icon
1
Bausch Health
BHC
$2.45B
$624M 13.46%
20,839,035
– –
GLD icon
2
SPDR Gold Trust
GLD
$149B
$617M 13.33%
4,320,022
– –
AGN
3
DELISTED
Allergan plc
AGN
$509M 10.99%
2,662,483
-269,687
-9% -$48.7M
DISCK
4
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
$333M 7.19%
10,922,500
– –
HZNP
5
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$296M 6.38%
8,170,700
– –
AU icon
6
AngloGold Ashanti
AU
$55.2B
$286M 6.16%
12,782,400
– –
TAK icon
7
Takeda Pharmaceutical
TAK
$58.9B
$261M 5.64%
13,244,711
– –
PARA
8
DELISTED
Paramount Global Class B
PARA
$252M 5.44%
+6,000,000
New +$232M
VTRS icon
9
Viatris
VTRS
$19.4B
$241M 5.21%
12,005,400
– –
AAMI
10
Acadian Asset Management
AAMI
$3.32B
$204M 4.41%
20,000,552
– –
NG icon
11
NovaGold Resources
NG
$3.54B
$197M 4.25%
21,992,896
– –
DISH
12
DELISTED
DISH Network Corp.
DISH
$176M 3.81%
4,973,500
– –
S
13
DELISTED
Sprint Corporation
S
$83.4M 1.8%
16,015,108
+3,429,408
+27% +$20.1M
PCRX icon
14
Pacira BioSciences
PCRX
$1.05B
$77.8M 1.68%
1,716,727
– –
TIMB icon
15
TIM SA
TIMB
$8.76B
$71.1M 1.53%
3,720,000
– –
ENDP
16
DELISTED
Endo International plc
ENDP
$40.5M 0.87%
8,626,900
– –
B
17
Barrick Mining
B
$73.7B
$38M 0.82%
2,041,728
+4,976
+0.2% +$85.4K
AEM icon
18
Agnico Eagle Mines
AEM
$104B
$37.4M 0.81%
607,600
– –
TMQ
19
Trilogy Metals
TMQ
$570M
$37.3M 0.8%
14,326,996
– –
THM
20
International Tower Hill Mines
THM
$657M
$32.2M 0.69%
59,593,314
– –
WCG
21
DELISTED
Wellcare Health Plans, Inc.
WCG
$30.7M 0.66%
93,046
-468,351
-83% -$141M
PVG
22
DELISTED
PRETIUM RESOURCES INC.
PVG
$28.8M 0.62%
+2,588,600
New +$27.5M
SSRM icon
23
SSR Mining
SSRM
$7.58B
$22.3M 0.48%
1,158,200
– –
NMRK icon
24
Newmark Group
NMRK
$2.76B
$20.9M 0.45%
1,550,000
-450,000
-23% -$5.25M
TECD
25
DELISTED
Tech Data Corp
TECD
$19.2M 0.41%
+133,426
New +$17.2M
1
2 3

Similar funds

TC
Trilogy Capital Irvine, California $2.58B AUM 22.97% 1-Year Est. Return
RFP
Root Financial Partners Encinitas, California $2.57B AUM 21.7% 1-Year Est. Return
EV
Eclipse Ventures Palo Alto, California $2.57B AUM
MC
Moors & Cabot Boston, Massachusetts $2.57B AUM 37.84% 1-Year Est. Return
PI
PFG Investments Woodbury, New York $2.58B AUM 36.93% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.57B AUM 67.1% 1-Year Est. Return
CTA
Chesley Taft & Associates Chicago, Illinois $2.57B AUM 22.93% 1-Year Est. Return
VWM
Venturi Wealth Management Austin, Texas $2.58B AUM 41.25% 1-Year Est. Return

Paulson & Co's Q4 2019 Portfolio in Review

As of Q4 2019, Paulson & Co held 51 positions worth $4.63B, down 7.2% from $4.99B the previous quarter. Its ten largest holdings account for 78% of the portfolio.

Paulson & Co withdrew a net $920M in Q4 2019, closing 14 positions and reducing 5 holdings. Its most notable exit was Celgene Corp, an estimated $317M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 45% of assets, down from 47% a quarter earlier, followed by Communication Services and Materials.

Against the trend, Paulson & Co opened a new position in Paramount Global Class B worth $252M.

  • Paulson & Co's largest Q4 2019 buy was Paramount Global Class B: 6,000,000 shares worth $252M.
  • Paulson & Co added most to Sprint Corporation in Q4 2019, an estimated $20.1M increase.
  • Paulson & Co's biggest Q4 2019 reduction was Wellcare Health Plans, Inc., cutting an estimated $141M.
  • Paulson & Co fully exited Celgene Corp in Q4 2019, selling an estimated $317M.
  • Paulson & Co's ten largest holdings make up 78% of its $4.63B portfolio in Q4 2019.
  • Paulson & Co opened 6 new positions and closed 14 in Q4 2019.
  • Paulson & Co's portfolio value fell 7.2% quarter-over-quarter to $4.63B.

Based on Paulson & Co's 13F filing for Q4 2019, filed 14 Feb 2020.